Skip to content

Author

Yi-Wei Sun

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Hypoxia-activated 2-nitroimidazole-brusatol carbonate prodrugs for enhanced gastric cancer therapy with reduced systemic toxicity.

This work describes the first hypoxia-activated BST prodrug with potent in vivo efficacy and improved safety, providing a targeted delivery strategy and a promising lead agent for gastric cancer treatment.

Ji-Chong Li, Xue-Lan Ma, Zi-Jian Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.